Search results
Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZ® ANDA...
WKRN Nashville· 4 days agoVanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the Supreme Court denied Vanda's petition for a writ of certiorari ...
Jefferies’s latest rating for VNDA stock – Knox Daily
Knox Daily· 3 days agoIn a filing, Vanda Pharmaceuticals Inc revealed its President and CEO Polymeropoulos Mihael Hristos unloaded Company’s shares for reported ...
Vanda (VNDA) to Report Q1 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 2 days agoOn Vanda's (VNDA) first-quarter 2024 earnings call, investors' focus is likely to be on the sales...
Butler Hall Capital LLC has issued an open letter to VNDA’s board of directors urging the company to...
Morningstar· 7 days agoBelieves the Substantial Premium Presented by Future Pak Merits Engagement Believes a Sales Process Could Yield Well Over 100% Upside to the Stock LOS ANGELES, April 19, 2024 (GLOBE NEWSWIRE) -- A fund managed by Butler Hall Capital LLC, with current
US Supreme Court reportedly declines to hear Vanda patent case (NASDAQ:VNDA)
Seeking Alpha· 4 days agoThe US Supreme Court has reportedly declined to hear Vanda Pharmaceuticals' (VNDA) case regarding...
Vanda under pressure from hedge fund to discuss Future Pak takeover offer
Seeking Alpha· 7 days agoButler Hall Capital urges Vanda Pharmaceuticals to discuss Future Pak's takeover bid, and calls for...
US Supreme Court Declines To Hear Vanda Pharmaceuticals' Case Regarding Invalidation Of Patents For...
Benzinga· 4 days agoThe U.S. Supreme Court has reportedly chosen not to review Vanda Pharmaceuticals Inc’s VNDA attempt...
U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents
Reuters· 4 days agoThe justices turned away Vanda's appeal of a ruling by the patent-focused U.S. Court of Appeals for...
Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals
Morningstar· 1 day agoReminds Vanda’s Board of Their Fiduciary Duties Given the Mishandling of Future Pak’s Offer to Acquire Vanda’s Underperforming and Undervalued Shares at an ~80-90% Premium Expresses Serious ...
Vanda Pharmaceuticals (NASDAQ:VNDA) Lowered to Hold at StockNews.com
ETF DAILY NEWS· 4 days agoStockNews.com downgraded shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Free Report) from a buy rating to a hold rating in a research report sent to investors on Monday morning. Separately, ...